<DOC>
	<DOCNO>NCT00253786</DOCNO>
	<brief_summary>Study effectiveness intensive therapy aim remission diabetic nephropathy</brief_summary>
	<brief_title>Study Effectiveness Intensive Therapy Aiming Remission Diabetic Nephropathy</brief_title>
	<detailed_description>Study effectiveness intensive therapy diabetic nephropathy unblinded , randomize intergroup comparison study .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>Type 2 diabetes mellitus Urinary albumin/creatinine ratio &gt; = 300mg/gCr Serum creatinine level &lt; 2.5mg/dL observation period Patients whose consent obtain age &gt; 20 year = &lt; 75 year Type 1 diabetes mellitus Hereditary diabetes mellitus secondary diabetes mellitus Nondiabetic nephropathy Familial hypercholesterolemia Secondary hypertension Unstable angina pectoris Myocardial infarction Cerebral hemorrhage Lifethreatening disease malignant tumor History angioedema Under LDLapheresis adsorbent dextran sulphate cellose Biliary obstruction Severe hepatopathy Hypergasia hepatic metabolism acute hepatitis Exacerbation chronic hepatitis Cirrhosis Hepatic cancer Jaundice History hypersensitivity ACE inhibitor History hypersensitivity ARB History hypersensitivity HMGCoA reductase inhibitor Pregnant , lactating , probably pregnant patient Patients want become pregnant study period Patients judged inappropriate subject</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>diabetes</keyword>
	<keyword>nephropathy</keyword>
</DOC>